Oarsman Capital’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9,698	Closed	-$12.5K	–	471
2024 Q4	$12.5K	Hold	9,698	–	–	﹤0.01%	663
2024 Q3	$26.7K	Buy	+9,698	New	+$26.7K	﹤0.01%	553